Ohmeda/MOVA to develop generic line of injectable anesthetics and related acute care products.
Executive Summary
OHMEDA/MOVA TO DEVELOP GENERIC LINE OF INJECTABLE ANESTHETICS and anesthesia-related acute care products under a 10-year collaboration agreement announced Oct. 5. Under the agreement, Ohmeda will be responsible for "analytical and process development, transfer of technology from research to full-scale manufacturing" and regulatory filings, the Liberty Corner, N.J.-based company said. Caguas, Puerto Rico-based MOVA will manufacture the products.